NCT00100477View on ClinicalTrials.gov

Use of Topotecan in Patients With Refractory Acute Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

January 31, 2001

Study Completion Date

June 30, 2001

Conditions
Non-Hodgkin's LymphomaLeukemia
Interventions
DRUG

Topotecan

DRUG

Mitozantrone

DRUG

Etoposide

Trial Locations (1)

32608

North Florida/South Georgia Veterans Health System, Gainesville

Sponsors
All Listed Sponsors
collaborator

Immunex Corporation

INDUSTRY

collaborator

SmithKline Beecham

INDUSTRY

collaborator

Amgen

INDUSTRY

lead

US Department of Veterans Affairs

FED